Niki BioSolutions, Inc. (NIKI)

US · Healthcare · Biotechnology

$1.58+5.33%

Last close · 2026-11-06

Latest quarter · ended 2025-12-31

Revenue

Net profit

$-307,495

Profit YoY

-111.6%

EPS

$-0.38

Market cap

$6.1M

Forward P/E

0.0

P/B

0.07

Book value

$26.75

EPS (TTM)

$-2.90

52-week high

$17.20

52-week low

$1.70

50-day MA

$4.76

200-day MA

$7.76

Beta

-1.00

Insiders

47.50%

Institutions

0.28%

Fund	Stake
Citadel Advisors Llc	0.30%
Advisor Group Holdings, Inc.	0.07%
SBI Securities Co Ltd	0.00%
Renaissance Technologies Corp	0.00%
BNP Paribas Arbitrage, SA	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Susquehanna International Group, LLP	0.00%
Two Sigma Investments LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Niki BioSolutions, Inc. — free to start.

Data updated 2026-11-07.